Krisztina Matúz

发表

Biochemical Characterization of Human Retroviral-Like Aspartic Protease 1 (ASPRV1)

J. Tőzsér, J. Mótyán, K. Nagy, 2020, Biomolecules.

Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus proteases.

I. Weber, R. Harrison, J. Tözsér, 2007, The Journal of general virology.

Biochemical Characterization, Specificity and Inhibition Studies of HTLV-1, HTLV-2, and HTLV-3 Proteases

J. Tőzsér, J. Mótyán, Maria Golda, 2021, Life.

Enhanced stability of monomer fold correlates with extreme drug resistance of HIV-1 protease.

J. Louis, J. Roche, Annie Aniana, 2013, Biochemistry.

Bovine Leukemia Virus Retropepsin

J. Tözsér, Tamás Sperka, Krisztina Matúz, 2013 .

Interactions of retinoids with the ABC transporters P-glycoprotein and Breast Cancer Resistance Protein

É. Csősz, L. Nagy, I. Holb, 2017, Scientific Reports.

C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity.

I. Weber, J. Tözsér, P. Bagossi, 2008, The Biochemical journal.

A Modular System to Evaluate the Efficacy of Protease Inhibitors against HIV-2

J. Tőzsér, F. Tóth, M. Mahdi, 2014, PloS one.

Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus‐related virus protease

A. Wlodawer, A. Gustchina, Mi Li, 2011, The FEBS journal.

Inhibition of XMRV and HIV‐1 proteases by pepstatin A and acetyl‐pepstatin

A. Wlodawer, Mi Li, J. Tőzsér, 2012, The FEBS journal.

Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors

J. Tőzsér, J. Mótyán, Krisztina Matúz, 2022, Viruses.